(NUTX) Nutex Health - Ratings and Ratios

Nutex Health Inc. is a physician-led healthcare services and operations company in the United States, operating through three key segments: Hospital, Population Health Management (PHM), and Real Estate. The companys PHM segment enables the establishment and operation of independent physician associations through its Management Services Organization (MSO), providing critical support services to affiliated hospitals and physician groups, as well as a cloud-based platform for healthcare organizations. Nutex Healths Hospital segment focuses on developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments, offering a range of healthcare services including emergency room care, inpatient care, behavioral health, and diagnostic imaging services. The Real Estate segment involves the ownership and leasing of land and hospital buildings, further diversifying the companys revenue streams.

With its foundation in 2011 and headquartered in Houston, Texas, Nutex Health has demonstrated significant growth and expansion in the healthcare sector. The companys business model is designed to provide comprehensive healthcare services, leveraging its MSO to support affiliated healthcare providers and its hospital network to deliver high-quality patient care. Nutex Healths cloud-based platform is a key differentiator, enabling healthcare organizations to streamline operations and improve efficiency.

Analyzing the provided and , we can observe that Nutex Healths stock has shown remarkable growth, with a current price of $117.42 and a 52-week high of $149.00. The stocks SMA20, SMA50, and SMA200 are $127.62, $84.80, and $42.99, respectively, indicating a strong upward trend. The ATR of 13.35 (11.37%) suggests moderate volatility. From a fundamental perspective, the companys Market Cap stands at $633.73M USD, with a P/E ratio of 11.81 and a Return on Equity (RoE) of 105.00, indicating strong profitability.

Based on the and , a forecast for Nutex Health Inc. can be derived. The stocks upward trend, supported by its SMA indicators, suggests potential for continued growth. However, the moderate volatility indicated by the ATR necessitates caution. Considering the companys strong RoE and expanding business model, a potential target price could be $180-$200 in the next 6-12 months, assuming the current growth trajectory continues and the company successfully executes its business strategy. Nevertheless, it is essential to closely monitor the stocks performance and adjust the forecast accordingly.